Overview

CKD-828 Primary Hypertension Trial(Dose-selection)

Status:
Completed

Trial end date:
2011-03-01

Target enrollment:

Participant gender:

Summary

The aim of this trial is to determine the best dose combination of S-Amlodipine and Telmisartan as compared to monotherapy by assessing the blood pressure lowering effects of a once daily regimen of various combinations of S-Amlodipine and Telmisartan, compared to their monotherapy components and placebo, in patients with stage I or II essential hypertension(a mean seated cuff diastolic blood pressure >=95 and <=115 mmHg).

Phase:

Phase 2

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Treatments:

Amlodipine
Niacin
Telmisartan